| Hepatocellular Carcinoma |
1 |
1 |
| Liver Transplantation |
0 |
0.7 |
| Cancer |
0 |
0.58 |
| Biologic Therapy |
0 |
0.55 |
| Metastasis |
0 |
0.52 |
| Liver |
0 |
0.48 |
| Transplantation |
0 |
0.42 |
| Biliary Disease |
0 |
0.38 |
| Resection |
0 |
0.32 |
| Tumor |
0 |
0.32 |
| HIV Infection |
0 |
0.29 |
| Addiction |
0 |
0.28 |
| Socioeconomics |
0 |
0.26 |
| Alcoholism |
0 |
0.24 |
| Cancer Staging |
0 |
0.22 |
| Cirrhosis |
0 |
0.21 |
| Social Determinants of Health |
0 |
0.19 |
| Hepatitis C Virus |
0 |
0.17 |
| Distant Metastasis |
0 |
0.15 |
| Hepatitis |
0 |
0.14 |
| Tobacco Use |
0 |
0.14 |
| Genomic Medicine |
0 |
0.13 |
| Ablation |
0 |
0.11 |
| Hepatitis A |
0 |
0.11 |
| HIV Coinfections |
0 |
0.11 |
| Immunotherapy |
0 |
0.11 |
| Radiofrequency Ablation |
0 |
0.11 |
| Surgery |
0 |
0.11 |
| Humanized Monoclonal Antibody |
0 |
0.09 |
| Thromboembolism |
0 |
0.09 |
| Tobacco Cessation |
0 |
0.09 |
| Electronic Health Record (EHR) |
0 |
0.07 |
| Tyrosine Kinase Inhibitor |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.06 |
| Alcohol Use |
0 |
0.05 |
| Angiogenesis Inhibitors |
0 |
0.05 |
| Autoimmune Disease |
0 |
0.05 |
| Cyclooxygenase (COX) |
0 |
0.05 |
| Embolization |
0 |
0.05 |
| Epidemiology |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| Health Care Inequities |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| ICD-9 and ICD-10 |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Monoclonal Antibody |
0 |
0.05 |
| Prognosis |
0 |
0.05 |
| Tennessee |
0 |
0.05 |
| Tyrosine Kinase |
0 |
0.05 |
| Wilson Disease |
0 |
0.05 |
| Wound Management |
0 |
0.03 |